• Je něco špatně v tomto záznamu ?

The Use of Assisted Reproductive Technology by European Childhood Cancer Survivors

A. Borgmann-Staudt, S. Michael, G. Sommerhaeuser, MJ. Fernández-González, LA. Friedrich, S. Klco-Brosius, T. Kepak, J. Kruseova, G. Michel, A. Panasiuk, S. Schmidt, L. Lotz, M. Balcerek

. 2022 ; 29 (8) : 5748-5762. [pub] 20220815

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22024831

CCS often wish to have biological children yet harbour concerns about fertility impairment, pregnancy risks and the general health risks of prospective offspring. To clarify these concerns, health outcomes in survivor offspring born following ART (n = 74, 4.5%) or after spontaneous conception (n = 1585) were assessed in our European offspring study by descriptive and bivariate analysis. Outcomes were compared to a sibling offspring cohort (n = 387) in a 4:1 matched-pair analysis (n = 1681). (i) Survivors were more likely to employ ART than their siblings (4.5% vs. 3.7%, p = 0.501). Successful pregnancies were achieved after a median of one cycle with, most commonly, intracytoplasmic sperm injection (ICSI) using non-cryopreserved oocytes/sperm. (ii) Multiple-sibling births (p < 0.001, 29.7% vs. 2.5%), low birth weight (p < 0.001; OR = 3.035, 95%-CI = 1.615-5.706), and preterm birth (p < 0.001; OR = 2.499, 95%-CI = 1.401-4.459) occurred significantly more often in survivor offspring following ART utilisation than in spontaneously conceived children. ART did not increase the prevalence of childhood cancer, congenital malformations or heart defects. (iii) These outcomes had similar prevalences in the sibling population. In our explorative study, we could not detect an influence on health outcomes when known confounders, such as multiple births, were taken into account.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22024831
003      
CZ-PrNML
005      
20221031100551.0
007      
ta
008      
221017s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/curroncol29080453 $2 doi
035    __
$a (PubMed)36005191
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Borgmann-Staudt, Anja $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany
245    14
$a The Use of Assisted Reproductive Technology by European Childhood Cancer Survivors / $c A. Borgmann-Staudt, S. Michael, G. Sommerhaeuser, MJ. Fernández-González, LA. Friedrich, S. Klco-Brosius, T. Kepak, J. Kruseova, G. Michel, A. Panasiuk, S. Schmidt, L. Lotz, M. Balcerek
520    9_
$a CCS often wish to have biological children yet harbour concerns about fertility impairment, pregnancy risks and the general health risks of prospective offspring. To clarify these concerns, health outcomes in survivor offspring born following ART (n = 74, 4.5%) or after spontaneous conception (n = 1585) were assessed in our European offspring study by descriptive and bivariate analysis. Outcomes were compared to a sibling offspring cohort (n = 387) in a 4:1 matched-pair analysis (n = 1681). (i) Survivors were more likely to employ ART than their siblings (4.5% vs. 3.7%, p = 0.501). Successful pregnancies were achieved after a median of one cycle with, most commonly, intracytoplasmic sperm injection (ICSI) using non-cryopreserved oocytes/sperm. (ii) Multiple-sibling births (p &lt; 0.001, 29.7% vs. 2.5%), low birth weight (p &lt; 0.001; OR = 3.035, 95%-CI = 1.615-5.706), and preterm birth (p &lt; 0.001; OR = 2.499, 95%-CI = 1.401-4.459) occurred significantly more often in survivor offspring following ART utilisation than in spontaneously conceived children. ART did not increase the prevalence of childhood cancer, congenital malformations or heart defects. (iii) These outcomes had similar prevalences in the sibling population. In our explorative study, we could not detect an influence on health outcomes when known confounders, such as multiple births, were taken into account.
650    12
$a přežívající onkologičtí pacienti $7 D000073116
650    _2
$a dítě $7 D002648
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    12
$a nádory $x epidemiologie $7 D009369
650    _2
$a těhotenství $7 D011247
650    _2
$a výsledek těhotenství $7 D011256
650    12
$a předčasný porod $x epidemiologie $7 D047928
650    _2
$a prospektivní studie $7 D011446
650    _2
$a asistovaná reprodukce $x škodlivé účinky $7 D027724
650    _2
$a sperma $7 D012661
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Michael, Simon $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany
700    1_
$a Sommerhaeuser, Greta $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany
700    1_
$a Fernández-González, Marta-Julia $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany
700    1_
$a Friedrich, Lucía Alacán $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany
700    1_
$a Klco-Brosius, Stephanie $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany
700    1_
$a Kepak, Tomas $u Department of Paediatric Oncology, Masaryk University, University Hospital Brno, 61137 Brno, Czech Republic $1 https://orcid.org/0000000214495273
700    1_
$a Kruseova, Jarmila $u Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, 15006 Prague, Czech Republic $1 https://orcid.org/0000000265767048
700    1_
$a Michel, Gisela $u Department of Health Sciences and Medicine, University of Lucerne, 6002 Luzern, Switzerland $1 https://orcid.org/0000000295890928
700    1_
$a Panasiuk, Anna $u Department of Oncology, Hematolgy and Transplantology, Medical University Wroclaw, 50-367 Wrocław, Poland $1 https://orcid.org/0000000161957955
700    1_
$a Schmidt, Sandrin $u Medical University Graz, 8036 Graz, Austria
700    1_
$a Lotz, Laura $u Department of Obstetrics and Gynaecology, Erlangen University Hospital, Friedrich-Alexander University of Erlangen-Nuremberg, 91054 Erlangen, Germany
700    1_
$a Balcerek, Magdalena $u Charité-Universitätsmedizin Berlin Germany, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Department of Paediatric Oncology, Haematology and Stem Cell Transplantation, 13353 Berlin, Germany $u Berlin Institute of Health (BIH), 10178 Berlin, Germany $1 https://orcid.org/0000000195314974
773    0_
$w MED00165427 $t Current oncology $x 1718-7729 $g Roč. 29, č. 8 (2022), s. 5748-5762
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36005191 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100549 $b ABA008
999    __
$a ok $b bmc $g 1854513 $s 1176121
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 29 $c 8 $d 5748-5762 $e 20220815 $i 1718-7729 $m Current oncology $n Curr. oncol. $x MED00165427
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace